Stay updated with breaking news from Bay Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net cash used in operating and investing activities was $5.1 million in the fourth quarter and $109.3 million for the full year of 2022; quarter-end cash and restricted cash position was $712.6 million
06.02.2023 - WARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor (CAR) T cell therapies for cancer, today announced that company management will participate in two upcoming investor...
The G7 Leaders have issued a joint statement, setting out principles and next steps to modernise the G7’s approach to infrastructure finance and
The G7 Leaders have issued a joint statement, setting out principles and next steps to modernise the G7's approach to infrastructure finance and narrow the infrastructure investment gap in developing countries.